Anesthetized pigs sustained a hypoxic cardiac arrest and a 15-minute warm ischemic standoff period. Strategy 1 hearts (S1, n = 9) underwent initial reperfusion with a cold hyperkalemic cardioplegia, normothermic EVHP, and transplantation after a cold hyperkalemic cardioplegic arrest (current EVHP strategy). Strategy 2 hearts (S2, n = 8) underwent initial reperfusion with a tepid adenosine-lidocaine cardioplegia, normothermic EVHP, and transplantation with continuous myocardial perfusion (cardioprotective EVHP strategy).
At completion of EVHP, S2 hearts exhibited less weight gain (9.7 ¡À 6.7 [S2] vs 21.2 ¡À 6.7 [S1] g/hour, p = 0.008) and less troponin-I release into the coronary sinus effluent (4.2 ¡À 1.3 [S2] vs 6.3 ¡À 1.5 [S1] ng/ml; p = 0.014). Mass spectrometry analysis of oxidized phosphatidylcholines in post-transplant myocardium revealed less oxidative stress in S2 hearts. At 30 minutes after wean from cardiopulmonary bypass, post-transplant systolic (pre-load recruitable stroke work: 33.5 ¡À 1.3 [S2] vs 19.7 ¡À 10.9 [S1], p = 0.043) and diastolic (isovolumic relaxation constant: 42.9 ¡À 6.7 [S2] vs 65.2 ¡À 21.1 [S1], p = 0.020) function were superior in S2 hearts.
In this experimental model of DCD, an EVHP strategy using initial reperfusion with a tepid adenosine-lidocaine cardioplegia and continuous myocardial perfusion minimizes myocardial injury and improves short-term post-transplant function compared with the current EVHP strategy using cold hyperkalemic cardioplegia before organ procurement and transplantation.